On Friday, Denali Therapeutics Inc (DNLI) stock saw a modest uptick, ending the day at $27.05 which represents a slight increase of $1.09 or 4.20% from the prior close of $25.96. The stock opened at ...
Denali Therapeutics Inc (NASDAQ:DNLI) shares are moving lower in Thursday’s after-hours session after the company announced that its Phase 2 study of oditrasertib was discontinued. What Happened ...
In a report released today, Michael Yee from Jefferies maintained a Buy rating on Denali Therapeutics (DNLI – Research Report), with a ...
On Monday, Denali Therapeutics Inc (DNLI) stock saw a modest uptick, ending the day at $27.78 which represents a slight increase of $1.63 or 6.23% from the prior close of $26.15. The stock opened at ...